Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial. - Burger AVM; Duinkerken CW; Jansen JC; Keereweer S; Cals FL; Stokroos RJ; de Boer JP; Exterkate L; van der Velden LA; Hoetink AE; Nuijen B; Hauptmann M; et al. (BMJ open, 2025)